PAPER Stephenson D, Rash K, Smalstig B, Roberts E, Johnstone E, Sharp J, Panetta J, Little S, Kramer R, Clemens J
SEARCH RESULTS
339239 RESULTS
PAPER Tolnay M, Probst A
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
Neuropathol Appl Neurobiol. 1999 Jun;25(3):171-87. PubMed.PAPER Athanassiadou A, Voutsinas G, Psiouri L, Leroy E, Polymeropoulos MH, Ilias A, Maniatis GM, Papapetropoulos T
Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.
Am J Hum Genet. 1999 Aug;65(2):555-8. PubMed.PAPER Pazmany T, Mechtler L, Tomasi TB, Kosa JP, Turoczi A, Urbanyi Z
Differential regulation of major histocompatibility complex class II expression and nitric oxide release by beta-amyloid in rat astrocyte and microglia.
Brain Res. 1999 Jul 24;835(2):213-23. PubMed.PAPER Suárez-Fernández MB, Soldado AB, Sanz-Medel A, Vega JA, Novelli A, Fernández-Sánchez MT
Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death.
Brain Res. 1999 Jul 24;835(2):125-36. PubMed.PAPER Wu C, Singh SK, Dias P, Kumar S, Mann DM
Activated astrocytes display increased 5-HT2a receptor expression in pathological states.
Exp Neurol. 1999 Aug;158(2):529-33. PubMed.PAPER Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH
Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.
Exp Neurol. 1999 Aug;158(2):469-90. PubMed.PAPER Ladner CJ, Lee JM
Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Exp Neurol. 1999 Aug;158(2):451-8. PubMed.PAPER Blackley HK, Patel N, Davies MC, Roberts CJ, Tendler SJ, Wilkinson MJ, Williams PM
Morphological development of beta(1-40) amyloid fibrils.
Exp Neurol. 1999 Aug;158(2):437-43. PubMed.PAPER Petronis A
Alzheimer's disease and down syndrome: from meiosis to dementia.
Exp Neurol. 1999 Aug;158(2):403-13. PubMed.PAPER Wang J, Dickson DW, Trojanowski JQ, Lee VM
The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.
Exp Neurol. 1999 Aug;158(2):328-37. PubMed.PAPER Nishiyama K, Trapp BD, Ikezu T, Ransohoff RM, Tomita T, Iwatsubo T, Kanazawa I, Hsiao KK, Lisanti MP, Okamoto T
Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease.
J Neurosci. 1999 Aug 1;19(15):6538-48. PubMed.PAPER Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM
Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors.
J Neurosci. 1999 Aug 1;19(15):6385-93. PubMed.PAPER Heun R
Validity of family history diagnosis for dementia.
Genet Epidemiol. 1999;17(2):151-4. PubMed.PAPER Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML, Lee VM, Trojanowski JQ
Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
J Comp Neurol. 1999 Aug 30;411(3):390-8. PubMed.Current Filters
No filters selected